Solasia Pharma KK 4597.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
134.00quote price arrow up+1.00 (+0.75%)
Volume
945,500
52 week range
111.00 - 204.00

...

Loading . . .
  • Open133.00
  • Day High134.00
  • Day Low130.00
  • Prev Close133.00
  • 52 Week High204.00
  • 52 Week High Date08/12/20
  • 52 Week Low111.00
  • 52 Week Low Date12/22/20

Key Stats

  • Market Cap156.89M
  • Shares Out129.49M
  • 10 Day Average Volume971,162.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change15.52

KEY STATS

  • Open133.00
  • Day High134.00
  • Day Low130.00
  • Prev Close133.00
  • 52 Week High204.00
  • 52 Week High Date08/12/20
  • 52 Week Low111.00
  • 52 Week Low Date12/22/20
  • Market Cap156.89M
  • Shares Out129.49M
  • 10 Day Average Volume971,162.5
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change15.52

RATIOS/PROFITABILITY

  • EPS (TTM)-21.40
  • P/E (TTM)-6.26
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Solasia Pharma KK

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System...
Yoshihiro Arai
President
Toshio Miyashita
Chief Financial Officer
Address
3F, Shiodome Bldg., 1-2-20, Kaigan
Minato-ku, TKY
105-0011
Japan